Study of 3D189 in Patients With Hematologic Malignancies

Clinical trial NCT05320809 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05320809
Sponsor: 3D Medicines
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemia Multiple Myeloma Non-Hodgkin Lymphoma Higher-risk Myelodysplastic Syndrome

Start date: 2022-08-01
Primary completion: 2026-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.